Roche Launches Eylea Competitor Vabysmo In India On The Heels Of Ocrevus
Seeks To Drive Access
Roche is stepping up its game in India with the launch of blockbuster Vabysmo (faricimab), closely on the heels of Ocrevus (ocrelizumab). It hopes to drive access for the nAMD and DME drug via government procurement and insurance schemes and tiered pricing.
